Name: Tirzepatide (TZ) – Dual GIP/GLP-1 Receptor Agonist – 10mg
Brand: CertPeptides
SKU: CP-TZ-10MG
Price: 89.99 USD
Availability: InStock

Product Description

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This 39-amino acid peptide has generated significant research interest for its unique dual-receptor mechanism, which differentiates it from single-receptor GLP-1 agonists in metabolic pathway studies.

Specifications

Molecular Weight	~4813.45 g/mol
Purity	≥98% (HPLC)
Physical Form	Lyophilized powder
Storage	-20°C, keep away from light and moisture

Research Applications

Glucose metabolism and insulin sensitivity studies
Appetite regulation pathway research
Dual incretin receptor signaling mechanisms
Metabolic syndrome modeling

Disclaimer: This product is intended for laboratory and research use only. Not for human or animal consumption. All handling should be conducted by qualified researchers in accordance with applicable regulations.

Certificate of Analysis

Every batch of Tirzepatide sold by CertPeptides is independently tested by a third-party laboratory. The Certificate of Analysis (COA) confirms identity, purity (≥98% via HPLC), and the absence of heavy metals and microbial contamination.

A COA is included with every order. You may also request a batch-specific COA through our contact page.

Laboratory Product Information

📦 Includes

One (1) vial of Tirzepatide lyophilized powder (10mg per vial), Certificate of Analysis (COA).

🔬 Purpose

Tirzepatide is a 39-amino-acid dual GIP/GLP-1 receptor agonist incorporating a C20 fatty diacid modification for extended half-life. It is utilized in in-vitro receptor binding and activation assays to characterize dual incretin agonist pharmacology, cAMP signaling, and receptor selectivity profiles.

🧬 Ingredients

Tirzepatide dual GIP/GLP-1 receptor agonist, 39-amino-acid peptide with C20 fatty diacid modification, ≥98% purity (HPLC verified). No fillers, binders, or excipients.

🔬 Laboratory Handling Information

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ (approximate; includes C20 fatty diacid modification)
Molecular Weight: ~4813.45 Da
Amino Acid Sequence: 39-amino-acid GIP-based peptide with structural modifications conferring GLP-1R co-agonism; Lys²⁰-linked C20 fatty diacid via γGlu-γGlu linker
Solubility: Soluble in sterile aqueous buffers (e.g., bacteriostatic water, PBS) at concentrations suitable for in-vitro applications
Storage: Store lyophilized product at 2–8°C; reconstituted aliquots at −20°C; avoid repeated freeze-thaw cycles
Literature Reference: Referenced at 1–100 nM for in-vitro GIPR/GLP-1R co-agonist binding and cAMP dose–response assays (PubMed: Jastreboff et al., N Engl J Med, 2022)

🚨 IMPORTANT — RESEARCH USE ONLY

FOR RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION. Not intended for any in vivo use, therapeutic, or diagnostic purpose. No dosing or administration information provided or implied.

🚚 Shipping

Ships in temperature-controlled packaging via priority courier. Most orders ship within 24 hours on business days. Free shipping on orders over $150. Tracking number provided via email upon shipment.

Tirzepatide (TZ) – Dual GIP/GLP-1 Receptor Agonist – 10mg